Rare side effect of treatment

Here the authors present a case of unilateral onycholysis in a patient receiving an EGFR tyrosine kinase inhibitor. In addition to describing a possible mechanism for this side effect, the authors also highlight the benefits of targeted therapy.

Seema Biswas
Editor-in-Chief

Unilateral onycholysis in a patient taking erlotinib (Tarceva)